| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-41295-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-65537-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-76557-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-52657-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-75899SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| IHC-Prediluted | NBP2-44554 | |||
| Azide and BSA Free | NBP2-34584-0.1mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-47820-0.1mg | |||
| IHC-Prediluted | NBP2-48466 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-34851-0.1mg | |||
| IHC-Prediluted | NBP2-44896 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| IHC-Prediluted | NBP2-44899 | |||
| Azide and BSA Free | NBP2-34586-0.1mg | |||
![Western Blot: CD55/DAF Antibody [NBP2-41295] - Western blot analysis of CD55/DAF expression in HeLa cell lysate with CD55/DAF antibody at (A) 1 and (B) 2 ug/ml.](http://images.novusbio.com/fullsize/CD55-DAF-Antibody-Western-Blot-NBP2-41295-img0004.jpg "Western Blot: CD55/DAF Antibody [NBP2-41295] - Western blot analysis of CD55/DAF expression in HeLa cell lysate with CD55/DAF antibody at (A) 1 and (B) 2 ug/ml.")
![Immunohistochemistry: CD55/DAF Antibody - BSA Free [NBP2-41295] - Immunohistochemistry of CD55/DAF in human lung tissue with CD55/DAF antibody at 5 ug/ml.](http://images.novusbio.com/fullsize/nbp2-41295_rabbit-polyclonal-cd55-daf-antibody-271120242013263.jpg)
![Immunocytochemistry/ Immunofluorescence: CD55/DAF Antibody - BSA Free [NBP2-41295] - Immunofluorescence of CD55/DAF in human lung tissue with CD55/DAF antibody at 20 ug/ml.](http://images.novusbio.com/fullsize/antibody/nbp2-41295_rabbit-polyclonal-cd55-daf-antibody-immunocytochemistry-immunofluorescence-19122024143314..jpg)
![Immunohistochemistry-Paraffin: CD59 Antibody (YTH53.1) [NB100-65537] Immunoperoxidase staining of formalin fixed, paraffin embedded human placenta with Rat anti Human CD59](http://images.novusbio.com/fullsize/CD59-Antibody-YTH53-1-Immunohistochemistry-Paraffin-NB100-65537-img0002.jpg "Immunohistochemistry-Paraffin: CD59 Antibody (YTH53.1) [NB100-65537] Immunoperoxidase staining of formalin fixed, paraffin embedded human placenta with Rat anti Human CD59")
![Flow Cytometry: CD59 Antibody (YTH53.1) [NB100-65537] - Staining of human peripheral blood granulocytes with RAT ANTI HUMAN CD59 (NB100-65537).](http://images.novusbio.com/fullsize/CD59-Antibody-YTH53-1-Flow-Cytometry-NB100-65537-img0001.jpg)
![Western Blot: CD229/SLAMF3/Lymphocyte Antigen 9 Antibody [NBP1-76557] - 293 cell lysate with Lymphocyte Antigen 9 antibody at (A) 1 and (B) 2 ug/mL.](http://images.novusbio.com/fullsize/CD229-SLAMF3-Lymphocyte-Antigen-9-Antibody-Western-Blot-NBP1-76557-img0001.jpg "Western Blot: CD229/SLAMF3/Lymphocyte Antigen 9 Antibody [NBP1-76557] - 293 cell lysate with Lymphocyte Antigen 9 antibody at (A) 1 and (B) 2 ug/mL.")
![Immunocytochemistry/ Immunofluorescence: CD229/SLAMF3/Lymphocyte Antigen 9 Antibody - BSA Free [NBP1-76557] - Immunocytochemistry of CD229/SLAMF3/Lymphocyte Antigen 9 in 293 cells with CD229/SLAMF3/Lymphocyte Antigen 9 antibody at 10 ug/mL.](http://images.novusbio.com/fullsize/nbp1-76557_rabbit-polyclonal-cd229-slamf3-lymphocyte-antigen-9-antibody-271120242042544.jpg)
![Immunocytochemistry/ Immunofluorescence: CD229/SLAMF3/Lymphocyte Antigen 9 Antibody - BSA Free [NBP1-76557] - Immunofluorescence of CD229/SLAMF3/Lymphocyte Antigen 9 in 293 cells with CD229/SLAMF3/Lymphocyte Antigen 9 antibody at 20 ug/mL.](http://images.novusbio.com/fullsize/nbp1-76557_rabbit-polyclonal-cd229-slamf3-lymphocyte-antigen-9-antibody-2711202419313292.jpg)
![Flow Cytometry: CD229/SLAMF3/Lymphocyte Antigen 9 Antibody (HLy9.25) [NBP1-50070] - Surface staining of human peripheral blood cells with anti-human CD229 (HLy9.25) PE.](http://images.novusbio.com/fullsize/CD229-SLAMF3-Lymphocyte-Antigen-9-Antibody-HLy9-25-Flow-Cytometry-NBP1-50070-img0002.jpg "Flow Cytometry: CD229/SLAMF3/Lymphocyte Antigen 9 Antibody (HLy9.25) [NBP1-50070] - Surface staining of human peripheral blood cells with anti-human CD229 (HLy9.25) PE.")
![Flow Cytometry: CD229/SLAMF3/Lymphocyte Antigen 9 Antibody (HLy9.25) [NBP1-50070] - Surface staining of human peripheral blood cells with anti-human CD229 (HLy9.25) APC.](http://images.novusbio.com/fullsize/CD229-SLAMF3-Lymphocyte-Antigen-9-Antibody-HLy9-25-Flow-Cytometry-NBP1-50070-img0001.jpg)
![Western Blot: HLA Class I Antibody [NBP2-75928] - Western blot analysis of HLA Class I on Hela cell lysate using anti-HLA Class I antibody at 1/1,000 dilution.](http://images.novusbio.com/fullsize/HLA-Class-I-Antibody-Western-Blot-NBP2-75928-img0008.jpg "Western Blot: HLA Class I Antibody [NBP2-75928] - Western blot analysis of HLA Class I on Hela cell lysate using anti-HLA Class I antibody at 1/1,000 dilution.")
![Flow Cytometry: HLA Class I Antibody [NBP2-75928] - analysis of Jurkat cells with HLA Class 1 ABC antibody at 1/100 dilution (red) compared with an unlabelled control (cells without incubation with primary antibody; black).](http://images.novusbio.com/fullsize/HLA-Class-I-Antibody-Flow-Cytometry-NBP2-75928-img0007.jpg)
![Immunohistochemistry-Paraffin: HLA Class I Antibody [NBP2-75928] - analysis of paraffin-embedded human colon cancer tissue using anti-HLA Class 1 ABC antibody. Counter stained with hematoxylin.](http://images.novusbio.com/fullsize/HLA-Class-I-Antibody-Immunohistochemistry-Paraffin-NBP2-75928-img0003.jpg)
![Immunohistochemistry-Paraffin: CEACAM-5/CD66e Antibody (CB30) [NB110-58734] - Human colorectal carcinoma](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-CB30-Immunohistochemistry-Paraffin-NB110-58734-img0002.jpg "Immunohistochemistry-Paraffin: CEACAM-5/CD66e Antibody (CB30) [NB110-58734] - Human colorectal carcinoma")
![Immunohistochemistry-Paraffin: CEACAM-5/CD66e Antibody (CB30) [NB110-58734] - Human colorectal carcinoma](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-CB30-Immunohistochemistry-Paraffin-NB110-58734-img0001.jpg)
![Flow Cytometry: CD52 Antibody (YTH 34.5-G2b (Campath-1G)) - Chimeric [NBP2-52657] - Flow-cytometry using the anti-CD52 research biosimilar antibody Campath-1G (YTH 34.5-G2b) Human lymphocytes were stained with an isotype control (panel A) or the rabbit-chimeric version of Campath-1G / YTH 34.5-G2b (NBP2-52657, panel B) at a concentration of 0.25 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/CD52-Antibody-YTH-34-5-G2b-Campath-1G-Chimeric-Flow-Cytometry-NBP2-52657-img0001.jpg "Flow Cytometry: CD52 Antibody (YTH 34.5-G2b (Campath-1G)) - Chimeric [NBP2-52657] - Flow-cytometry using the anti-CD52 research biosimilar antibody Campath-1G (YTH 34.5-G2b) Human lymphocytes were stained with an isotype control (panel A) or the rabbit-chimeric version of Campath-1G / YTH 34.5-G2b (NBP2-52657, panel B) at a concentration of 0.25 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.")
![Western Blot: CD52 Antibody (YTH 34.5-G2b (Campath-1G)) [NBP2-75899] - Mouse spleen samples were resolved on a 15% SDS PAGE gel and blots probed with the rat IgG1-chimeric version of YTH 34.5-G2b (NBP2-75899) at 1.5 ug/ml before detection using an anti-rat secondary antibody. Protein was detected by chemiluminescence. The expected unmodified running size for CD52 is ~8kDa, but this protein is extensively glycosylated and exhibits running sizes of ~11-25kDa. NBP2-75899 successfully detected CD52 in mouse spleen samples.](http://images.novusbio.com/fullsize/CD52-Antibody-YTH-34-5-G2b-Campath-1G-Western-Blot-NBP2-75899-img0001.jpg "Western Blot: CD52 Antibody (YTH 34.5-G2b (Campath-1G)) [NBP2-75899] - Mouse spleen samples were resolved on a 15% SDS PAGE gel and blots probed with the rat IgG1-chimeric version of YTH 34.5-G2b (NBP2-75899) at 1.5 ug/ml before detection using an anti-rat secondary antibody. Protein was detected by chemiluminescence. The expected unmodified running size for CD52 is ~8kDa, but this protein is extensively glycosylated and exhibits running sizes of ~11-25kDa. NBP2-75899 successfully detected CD52 in mouse spleen samples.")
![Immunocytochemistry/Immunofluorescence: CD6 Antibody (C6/372) [NBP2-32827] - Immunofluorescence staining of MOLT-4 cells using CD6 Antibody (C6/372) followed by goat anti-Mouse IgG conjugated to CF488 (green). Nuclei are stained with Red Dot.](http://images.novusbio.com/fullsize/CD6-Antibody-C6-372-Immunocytochemistry-Immunofluorescence-NBP2-32827-img0002.jpg "Immunocytochemistry/Immunofluorescence: CD6 Antibody (C6/372) [NBP2-32827] - Immunofluorescence staining of MOLT-4 cells using CD6 Antibody (C6/372) followed by goat anti-Mouse IgG conjugated to CF488 (green). Nuclei are stained with Red Dot.")
![Immunohistochemistry-Paraffin: CD6 Antibody (C6/372) [NBP2-32827] - Formalin-fixed paraffin-embedded human tonsil stained with CD6 Monoclonal Antibody (C6/372)](http://images.novusbio.com/fullsize/CD6-Antibody-C6-372-Immunohistochemistry-Paraffin-NBP2-32827-img0001.jpg)
![Immunohistochemistry-Paraffin: CD59 Antibody (MACIF/629) [NBP2-44700] - Formalin-fixed, paraffin-embedded human Tongue stained with CD59 Antibody (MACIF/629).](http://images.novusbio.com/fullsize/CD59-Antibody-MACIF-629-Immunohistochemistry-Paraffin-NBP2-44700-img0003.jpg "Immunohistochemistry-Paraffin: CD59 Antibody (MACIF/629) [NBP2-44700] - Formalin-fixed, paraffin-embedded human Tongue stained with CD59 Antibody (MACIF/629).")
![Immunohistochemistry-Paraffin: CD59 Antibody (MACIF/629) [NBP2-44700] - Human Tongue stained with CD59 Monoclonal Antibody (MACIF/629)](http://images.novusbio.com/fullsize/CD59-Antibody-MACIF-629-Immunohistochemistry-Paraffin-NBP2-44700-img0001.jpg)
![Immunohistochemistry-Paraffin: CEACAM5/CD66e Antibody (SPM584) [NBP2-33009] - Human Colon Carcinoma stained with CEACAM5/CD66e Antibody (SPM584).](http://images.novusbio.com/fullsize/CEACAM5-CD66e-Antibody-SPM584-Immunohistochemistry-Paraffin-NBP2-33009-img0006.jpg "Immunohistochemistry-Paraffin: CEACAM5/CD66e Antibody (SPM584) [NBP2-33009] - Human Colon Carcinoma stained with CEACAM5/CD66e Antibody (SPM584).")
![Immunohistochemistry-Paraffin: CEACAM5/CD66e Antibody (C66/261) [NBP2-33010] - Human Colon Carcinoma stained with CEACAM5/CD66e Antibody (C66/261).](http://images.novusbio.com/fullsize/CEACAM5-CD66e-Antibody-C66-261-Immunohistochemistry-Paraffin-NBP2-33010-img0003.jpg "Immunohistochemistry-Paraffin: CEACAM5/CD66e Antibody (C66/261) [NBP2-33010] - Human Colon Carcinoma stained with CEACAM5/CD66e Antibody (C66/261).")
![Immunohistochemistry-Paraffin: CEACAM5/CD66e Antibody (C66/261) [NBP2-33010] - Human Colon Carcinoma stained with CEACAM5/CD66e Antibody (C66/261).](http://images.novusbio.com/fullsize/CEACAM5-CD66e-Antibody-C66-261-Immunohistochemistry-Paraffin-NBP2-33010-img0002.jpg)